Antiretroviral boosters (Formulary)

MHRA alert: Cobicistat, ritonavir and coadministration with a steroid: risk of systemic corticosteroid adverse effects (December 2016).

COBICISTAT

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablet 150mg (specialist use only)

RITONAVIR

Important: Therapy notes

MHRA advice: Ritonavir-containing products: reports of interaction with levothyroxine leading to reduced thyroxine levels (October 2018).

  • In NHS Highland ritonavir is used as a booster for protease inhibitors rather than as a protease inhibitor itself. 

Important: Formulation and dosage details

Formulation:

Tablet 100mg (specialist use only)

Dosage:

Homecare is the preferred option - contact nhsh.homecare@nhs.scot

Editorial Information

Document Id: F285